Shows
MS-Perspektive - The Multiple Sclerosis PodcastNew Research for Managing Primary Progressive Multiple Sclerosis (PPMS) an ECTRIMS SpecialLatest treatments and research presented at ECTRIMS 2024 for managing primary progressive MS (PPMS). including innovative therapies like CAR T-cell therapy. You can read the full article on my blog: https://ms-perspektive.com/098-ppms-ectrims Primary Progressive Multiple Sclerosis (PPMS) presents unique challenges, as it often worsens without relapses and can significantly impact daily life. However, the growing body of research and treatment options is providing new hope for managing this condition. From exploring the effectiveness of established therapies like Ocrelizumab to cutting-edge advancements in CAR T-cell treatments, scientists and healthcare providers are uncovering ways to slow...2025-01-2931 min
RealTalk MSEpisode 383: Revisiting ECTRIMS 2024 with Dr. Bruce Bebo and Kristine Werner OzugOne of the most important MS research events every year is the annual European Committee for Treatment and Research in MS Scientific Congress, usually referred to by its acronym, ECTRIMS. You've made our podcast episode that followed ECTRIMS the most downloaded episode of the year. So, this week, I'm revisiting the two conversations that I had immediately after the ECTRIMS conference ended. In what has become an annual tradition, it's my privilege to sit down with the National MS Society's Executive Vice-President of Research, Dr. Bruce Bebo, just minutes after the conclusion of ECTRIMS to get his first impr...2024-12-3128 min
MS-Perspektive - The Multiple Sclerosis PodcastAging with MS an ECTRIMS SpecialExplore aging's impact on MS, highlighting research on cognition, inflammation, brain changes, and treatments. You can read the text version on my blog: https://ms-perspektive.com/093-aging-with-ms Living with multiple sclerosis in old age presents a unique challenge in understanding how the disease interacts with the natural aging process. This special ECTRIMS Review delves into groundbreaking studies exploring aging with MS, focusing on topics such as cognitive health, inflammation, brain changes, and diagnostic tools like OCT. Whether you are gaining insights into how MS develops in older age or looking for ways to proactively manage...2024-12-2533 min
The ECTRIMS PodcastAdvancing MS Knowledge through the ECTRIMS FellowshipThe recent ECTRIMS 2024 in Copenhagen showcased the work of young scientific investigators, including this year's ECTRIMS Fellowship recipients Oscar Ayala from Colombia and Zuhal Abasiyanik from Turkey. Every year, ECTRIMS awards fellowships across various categories to promote knowledge and expertise in the field of multiple sclerosis (MS). Oscar and Zuhal spoke with host Brett Drummond of MSTranslate about the research projects that they will be pursuing and how they believe this opportunity will impact their career. The ECTRIMS Fellowship application period for the 2025 cycle is now open. Apply before the deadline of December 1, 2024 at 23:59 CET.2024-12-2316 min
MS-Perspektive - The Multiple Sclerosis PodcastNew treatment strategies in MS an ECTRIMS SpecialLearn more about new treatment for MS, focusing on innovative therapies like engineered vesicles, CAR-T, CD40L and high-dose vitamin D. To read the full article visit my blog article: https://ms-perspektive.com/091-new-treatment-strategies This time, I will present some studies on new treatment options for MS that show promising results and were presented at ECTRIMS 2024. Some candidates are not that new, such as high-dose vitamin D, but the key here is the long-term observation of a large number of MS patients under clearly defined conditions. Furthermore, there are engineered extracellular vesicles (EVs), CAR-T cell th...2024-12-1127 min
MS-Perspektive - The Multiple Sclerosis PodcastUnderstanding the Hidden Challenges of MS: Sexual, Bladder, and Bowel Health an ECTRIMS SpecialLearn more about the impact of sexual, bladder, and bowel issues in MS and the importance of tailored care to improve quality of life. You can read the corresponding article here: https://ms-perspektive.com/89-sexual-bladder-bowel Living with MS means coping with a complex mix of symptoms that can affect both physical and emotional well-being. These include sensitive topics such as sexual health and bladder or bowel problems – issues that are not always discussed openly but are incredibly important for quality of life. Recent research and initiatives are shedding light on these areas and offering new in...2024-11-2722 min
AMSEL für die Ohren – Dein Multiple-Sklerose-Podcast#052 – ECTRIMS 2024 - BTKi und Diagnosekriterien#052 – ECTRIMS 2024 - BTKi und Diagnosekriterien mit Prof. Mathias Mäurer
______________
Multiple Sklerose und Neuerkrankt? https://www.amsel.de/erstdiagnose/
Weitere Informationen zur Multiplen Sklerose mehrmals die Woche: https://amsel.de
Exklusive Informationen rund um MS: https://www.amsel.de/plus
Multiple Sklerose und Ernährung: https://amsel.de/ernaehrung
Multiple Sklerose Forum: https://www.amsel.de/forum
Spenden für Multiple Sklerose Betroffene: https://amsel.de/spende
Unsere weiteren Social-Media-Kanäle: https://www.amsel.de/community/social-media/
AMSEL Mitglied werden: https://www.amsel.de/mitgliedschaft
Multiple Sklerose Podcast: https://www.amsel.de/community/ms-podcast/
Weitere Fragen rund u...2024-11-2216 min
MS-Perspektive - The Multiple Sclerosis PodcastNavigating Menopause with MS – Key insights on symptom progression, aging, and personalized care (ECTRIMS Special)Find out how the menopause affects MS. What new research reveals about progression, symptom management, biological aging and quality of life. You can read the full article here: https://ms-perspektive.com/86-ectrims-menopause If you’re living with MS and approaching menopause, you might wonder how this life stage could impact your MS journey. Menopause is already a significant transition, bringing physical, emotional, and social changes. When combined with MS, it can feel even more complex, and many women have questions about how menopause might influence their symptoms, progression, and overall quality of life. Fortunately, new re...2024-11-0622 min
MS-Perspektive - The Multiple Sclerosis PodcastECTRIMS Special on innovative MS rehabilitation for better quality of lifeNew approaches to MS Rehabilitation: From Telerehab to Ocean Sailing and individualized trainings plans for improved wellness. You can read the complete article here: https://ms-perspektive.com/085-ectrims-rehab Rehabilitation for multiple sclerosis (MS) is rapidly evolving, with exciting new approaches tailored to the unique needs of people with progressive MS (PwPMS). Recent studies have explored how various types of personalized therapies can improve both physical and mental well-being, offering a wider range of options for supporting a fulfilling, active life with MS. The article discusses innovative rehabilitation methods such as cognitive-affective profiling, sleep...2024-10-3017 min
RealTalk MSECTRIMS Research Roundup Part 2 with Dr. Bruce BeboNow that he's had a chance to digest all of the research presented at ECTRIMS, Dr. Bruce Bebo, the National MS Society's Executive Vice President of Research, is back to share the key research presented at the largest MS research conference in the world. This episode of RealTalk MS is the perfect follow-up to my initial conversation with Bruce, which occurred just minutes after ECTRIMS ended. (If you missed our conversation, you may want to check out Episode 369 of RealTalk MS.) We have a lot to talk about! Are you ready for RealTalk MS??! 2024-10-2227 min
MS-Perspektive - der Multiple Sklerose Podcast7. MS-Kamingespräch zum ECTRIMS 2024 und Patient Community DayNadja berichtet von ihren Live-Eindrücken vom ECTRIMS und Patient Community Day in m Zwiegespräch mit Nele, die digital teilgenommen hat. Du kannst das Interview auf meinem Blog Nachlesen: https://ms-perspektive.de/ms-kamingespraech-ectrims-2024 Diesmal dreht sich alles um die neuesten Eindrücke und Erkenntnisse von der ECTRIMS-Konferenz 2024, vor allem dem Patient Day. Nadja war live vor Ort in Kopenhagen, während ich die Veranstaltung online mitverfolgt habe. Gemeinsam sprechen wir über einige spannende Paper und Präsentationen, darunter die neuen McDonald’s-Kriterien zur MS-Diagnose und interessante Studienergebnisse. Besonders im Fokus steht der Patient...2024-10-1838 min
MS-Perspektive - der Multiple Sklerose PodcastECTRIMS Spezial: Deeskalieren und Absetzen von Therapien bei MS – Was bedeutet das und wie kann es funktionieren?Wann kann man über das Deeskalieren oder gar Absetzen einer hochwirksamen Immuntherapie nachdenken und was gilt es dabei zu beachten? Die schriftliche Version zum Nachlesen gibt es auf meinem Blog: https://ms-perspektive.de/ectrims-deeskalieren Hallo und willkommen zu einer weiteren Zusammenfassung vom ECTRIMS 2024, in der es diesmal um das Deeskalieren und das Absetzen der Therapie geht. Dazu gab es sowohl eine wissenschaftliche Vortragsreihe mit sechs Vorträgen, die von Dr. Melinda Magyari und Prof. Bernhard Hemmer moderiert wurde. Und außerdem noch einzelne Poster. Abgesehen von einer Arbeit über NMOSD und MOGAD beschäfti2024-10-1735 min
MS-Perspektive - The Multiple Sclerosis PodcastECTRIMS Special on De-escalation and discontinuation of therapies for MS – What does it mean and how can it work?When can we consider de-escalation or even discontinuation of a high-efficient immunotherapy for MS without risking a disease worsening? You can read the full article on my blog: https://ms-perspektive.com/83-deescalation Hello and welcome to another summary of ECTRIMS 2024, this time on the topic of de-escalation and discontinuation of therapy. There was a scientific session on this topic with six lectures, moderated by Dr. Melinda Magyari and Prof. Bernhard Hemmer. And there were also individual posters. Except for one talk about NMOSD and MOGAD, all scientific contributions we2024-10-1633 min
DyNAMICS HighlightsEP 38 - Novità dal congresso ECTRIMS 2024 - D. FerraroDurante il congresso ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis), tenutosi a Copenhagen tra il 18 ed il 20 settembre 2024, sono state brevemente illustrate le nuove revisioni ai criteri diagnostici per la Sclerosi Multipla.Tra le modifiche di maggior rilievo vi è la possibilità di effettuare diagnosi di Sclerosi Multipla anche in soggetti asintomatici con lesioni tipiche alla RM (RIS), l'aggiornamento dei criteri di disseminazione spaziale (DIS), l'abolizione del requisito della disseminazione temporale (DIT), l'aggiunta di alcuni tools opzionali neuroradiologici (lesioni con segno della vena centrale o con orletto paramagnetico) e l'inserimento delle catene leggere libere kappa liquorali come st...2024-10-1107 min
The ECTRIMS PodcastMS Nurses at ECTRIMS 2024Nurses play a specialised and unique role in the journey of people living with multiple sclerosis (MS). At ECTRIMS 2024, MS nurses showcased their experiences and insights into how to effectively support patients. In this episode, host Brett Drummond of MSTranslate talks with veteran MS nurses K-J Lazarus of Austin Health in Australia and Fiona d'Young of the Auckland Hospital in New Zealand.2024-10-1026 min
The ECTRIMS PodcastPatient Community Day Highlights of ECTRIMS 2024: Part IIThe Patient Community Day of ECTRIMS 2024 brought together people living with multiple sclerosis (MS), medical professionals, researchers, and advocates in two interactive sessions. They explored the forefront of MS research and treatment, focusing on groundbreaking topics like remyelination and myelin repair. They disussed promising new therapies that could revolutionise patient care, along with practical lifestyle changes and effective symptom management strategies. In Part II of our Patient Community Day episode, host Brett Drummond of MSTranslate talks to Sumaira Ahmed and Trevis Gleason, who are living with NMOSD and MS, respectively, about their experience attending the event.2024-10-0917 min
RealTalk MSECTRIMS Extra: Results from the Tolebrutinib Phase 3 Clinical Trial for Relapsing MS with Dr. Jiwon Oh With more than 9,000 MS researchers and clinicians in attendance, the 2024 ECTRIMS meeting in Copenhagen was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Jiwon Oh. Dr. Oh is a neurologist, scientist, and the Medical Director of the Barlo Multiple Sclerosis Program at St. Michael’s Hospital in Ontario, Canada. Dr. Oh is also the Principal Investigator in...2024-10-0408 min
HealthTalk-podcastenECTRIMS Oppsummert: Dette er de viktigste fremskrittene innen forskning på multippel sklerose (MS)Den europeiske MS-kongressen ECTRIMS i København samlet nylig over 8500 deltakere fra hele verden. Blant de viktigste temaene som ble diskutert, var studier på tidlig MS-behandling, oppdateringer på diagnosekriterier og nye legemidler for progressiv MS.For å oppsummere årets kongress, har HealthTalk-podcasten fått storfint besøk av:- Trygve Holmøy, professor og overlege ved Universitetet i Oslo og Akershus universitetssykehus (Ahus)- Gro Owren Nygaard, forsker og overlege ved Universitetet i Oslo og Oslo universitetssykehus (OUS)I episoden kommer vi blant annet inn på:Vitamin...2024-10-0340 min
The ECTRIMS PodcastPatient Community Day Highlights of ECTRIMS 2024: Part IThe Patient Community Day of ECTRIMS 2024 brought together people living with multiple sclerosis (MS), medical professionals, researchers, and advocates in two interactive sessions. They explored the forefront of MS research and treatment, focusing on groundbreaking topics like remyelination and myelin repair. They disussed promising new therapies that could revolutionise patient care, along with practical lifestyle changes and effective symptom management strategies. In Part 1 of our Patient Community Day episode, Elisabeth Kasilingam, Chief Executive Officer of the European Multiple Sclerosis Platform (EMSP) and Vice President of the European Patients’ Forum, talks with host Brett Drummond of MSTranslate about br...2024-10-0316 min
BeewellwithMS podcast by Dr Agne StraukieneECTRIMS 2024 Insights: Emerging MS Treatments, Diagnosis Updates, and Innovations in Multiple Sclerosis CareIn this episode of the BeeWellWithMS podcast, hosted by Dr. Agne Straukiene, an MS neurologist, key insights and reflections from the ECTRIMS 2024 conference in Copenhagen are shared. The event, featuring over 8,000 attendees, spotlighted emerging MS treatments, including high-dose vitamin D3, BTK inhibitor from the Hercules and Gemini two trials, and the updated McDonald criteria for MS diagnosis. Various interviews with MS experts and MS patients provide further discussion on topics such as MS fatigue, MS sleep disorders, cognitive function in MS, and the potential role of digital technology in MS treatment and holistic patient care. Despite some disappointing findings regarding...2024-10-0217 min
RealTalk MSECTRIMS Extra: Revisions to the Way MS is Diagnosed with Dr. Peter Calabresi With more than 9,000 MS researchers and clinicians in attendance, the 2024 ECTRIMS meeting in Copenhagen was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Peter Calabresi. Dr. Peter Calabresi is the Director of the Division of Neuroimmunology and the Director of the Multiple Sclerosis Center at Johns Hopkins Medicine. He is the principal investigator on several clinical t...2024-09-2809 min
RealTalk MSECTRIMS Extra: Rachel Horne and Professor Kerstin Helwig With more than 9,000 MS researchers and clinicians in attendance, the 2024 ECTRIMS meeting in Copenhagen was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Rachel Horne and Professor Kerstin Hellwig. Professor Kerstin Hellwig is the 2024 recipient of the Rachel Horne Prize for Women's Research in MS. Professor Hellwig was honored at ECTRIMS for her pioneering research into understanding a...2024-09-2611 min
NTD/NeuroTransData - ambulante Neurologie optimieren!Staffel 2, Folge 1: ECTRIMS 2024Thomas und Martin über die dänische Königin, die sie leider nicht gesehen haben. Außerdem über die neuen McDonald-Kriterien, über Tolebrutinib und andere Highlights vom vierzigsten ECTRIMS Kongress in Kopenhagen.2024-09-2531 min
RealTalk MSECTRIMS 2024 with Kristine Werner Ozug and Dr. Bruce BeboECTRIMS 2024, the largest MS research conference in the world concluded last week, and in this week's episode, we'll be hearing two slightly different perspectives on which news, announcements, and presentations stood out at this year's meeting. The ECTRIMS conference can feel almost overwhelming. You find yourself among 9 or 10 thousand other attendees, trying to determine which of the more than 1700 scientific presentations you want to learn more about. It's both a marathon and a sprint that seem to be taking place simultaneously. Kristine Werner Ozug is a member of the RealTalk MS team and a person w...2024-09-2430 min
MS-Selfie#1 ECTRIMS 2024 - battle of the BTKi'sThere are too many ECTRIMS 2024 highlights to cover in one newsletter. However, the top of the list of highlights was the positive tolebrutinib results in non-relapsing (inactive) secondary progressive MS. At the bottom was the negative, but not unexpected, simvastatin trial in SPMS.Tolebrutinib Tolebrutinib, a second-generation BTK inhibitor (BTKi), has a dual mode of action in MS. It inhibits BTK in B-cells and is an anti-inflammatory therapy. In both the relapsing and non-relapsing progressive MS trials, it had a relatively modest impact on relapses and focal MRI activity and more or less matched the a...2024-09-2315 min
RealTalk MSECTRIMS EXTRA: New Course Descriptors for MS with Dr. Fred Lublin With more than 9,000 MS researchers and clinicians in attendance, the 2024 ECTRIMS meeting in Copenhagen was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Fred Lublin. Dr. Fred Lublin is the Director of the Corrine Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai. He participated in the development of the very first disease-modifying therapy that was a...2024-09-2107 min
The ECTRIMS PodcastDay 3 Highlights of ECTRIMS 2024Former ECTRIMS President and MS Journal Editor-in-Chief Alan Thompson and host Brett Drummond wrap up the last day of ECTRIMS 2024 with their final thoughts and insights.2024-09-2021 min
MS TalkEctrims 2024
BREAKING NEWS!
Vandaag, 20 september 2024, is de laatste dag van de Ectrims in Kopenhagen; hèt wereldwijde congres voor neurologen met betrekking tot MS. Met de grootste doorbraak op MS gebied hebben ze tot de laatste dag gewacht. Een doorbraak die wellicht een verandering gaat betekenen in de behandeling van de ziekte MS.
Vanaf het vliegveld in Kopenhagen vertelt Gerald Hengstman aan Nanda Felderhof wat hij heeft gehoord deze laatste dag en wat er over deze ontdekking bekend is en wat dit mogelijk gaat betekenen in de MS wereld.
Onze excuses voor de verminderde geluidskwaliteit van deze aflevering, we wilden d...2024-09-2017 min
The ECTRIMS PodcastDay 2 Highlights of ECTRIMS 2024Anne Helme, Head of Research at MSIF, and host Brett Drummond discuss the key takeaways unveiled on the second day of ECTRIMS 2024 in Copenhagen, as well as the value of global collaboration.2024-09-1923 min
MS-Perspektive - The Multiple Sclerosis PodcastSpecial: ECTRIMS 2024 - Personalized MS treatments, genetic risk factors and the benefits of early, effective therapies for women and childrenPersonalized treatments, genetic risk factors, gender differences and the advantages of early, highly effective therapies. You can read the full article here: https://ms-perspektive.com/ectrims-2024-ww1 This year, ECTRIMS 2024 in Copenhagen, Denmark, will once again bring together leading experts in multiple sclerosis (MS) from around the world. The prestigious conference is the premier event for researchers, physicians and healthcare professionals all working towards a common goal: improving quality of life through groundbreaking research and advances in the treatment of MS and related diseases. The event, which is expected to attract around 9,000 attendees, promises a r...2024-09-1919 min
MS-Perspektive - der Multiple Sklerose PodcastECTRIMS 2024 – Personalisierte MS-Behandlungen, genetische Risikofaktoren und Vorteile früher, wirksamer Therapien für Frauen und KinderPersonalisierte Behandlungen, genetische Risikofaktoren, geschlechtsspezifische Unterschiede und Vorteile früher, hochwirksamer Therapien. Hier kannst du den kompletten Beitrag nachlesen: https://ms-perspektive.de/ectrims-2024-1 Dieses Jahr kommen auf der ECTRIMS 2024 in Kopenhagen, Dänemark, wieder führende Experten für Multiple Sklerose (MS) aus der ganzen Welt zusammen. Die renommierte Konferenz ist die wichtigste Veranstaltung für Forscher, Ärzte und medizinisches Fachpersonal, die alle auf ein gemeinsames Ziel hinarbeiten: die Verbesserung der Lebensqualität durch bahnbrechende Forschung und Fortschritte bei der Behandlung von MS und verwandten Krankheiten. Die Veranstaltung, zu der rund 9.000 Teilnehmer erwartet werden, verspri...2024-09-1922 min
The ECTRIMS PodcastDay 1 Highlights of ECTRIMS 2024ECTRIMS Vice President Bruno Stankoff highlights the most relevant insights from day one of ECTRIMS 2024 in Copenhagen, and provides a glimpse of what to expect from the ECTRIMS society in the coming year.2024-09-1819 min
Nervennahrung Neurologie PodcastECTRIMS Kongress 2024 Neuro News aus Kopenhagen, Folge 1 | Nervennahrung Podcast
Heute berichten Prof. Sven Meuth, Universitätsklinikum Düsseldorf, und Prof. Frank Leypoldt, Universitätsklinikum Schleswig-Holstein, vom ECTRIMS Kopenhagen über neue klinisch relevante Erkenntnisse rund um die Neurologie mit einem besonderen Fokus auf den Pre-Day des Kongresses.
2024-09-1822 min
The ECTRIMS PodcastPre-Day Highlights of ECTRIMS 2024Listen to Romain Marignier from CHU de Lyon and host Brett Drummond discuss highlights of ECTRIMS' new Pre-Day on NMOSD, MOGAD, and other rare neurological conditions.2024-09-1717 min
The Raw NerveEp40 ECTRIMS 2024: Shaping the future of MS researchIn the latest episode of the Raw Nerve recorded on Friday 13 September, guests Julia Morahan and Heidi Beadnall sit down with the CEO of MS Australia to dive deep into the highlights of the upcoming ECTRIMS 2024 (18-20 September) – the world’s largest MS research congress. The event, attracting over 10,000 delegates from around the globe, serves as a crucial platform for researchers, clinicians, and healthcare professionals to explore and advance the latest in MS research and treatment.
Join the discussion as they explore the revised McDonald Criteria, which bring updated diagnostic guidelines for MS, enhancing early diagnosis and tailo...2024-09-1627 min
The ECTRIMS PodcastECTRIMS-EAN Vaccination Consensus Statement (eanCast)The following episode has been produced by the European Academy of Neurology (EAN) in collaboration with the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), and has been published on both the EAN and ECTRIMS Podcast channels to ensure our joint communities have access to it. In this episode of eanCast: Weekly Neurology, host Melinda Magyari is joined by ECTRIMS Podcast host Brett Drummond to talk about the ECTRIMS-EAN Vaccination Consensus Statement with lead author Susana Otero of the Department of Preventive Medicine and Epidemiology, Vall d'Hebron Barcelona Hospital, Barcelona, Spain and the Multiple Sclerosis...2024-09-0433 min
eanCast: Weekly NeurologyEp. 111: ECTRIMS-EAN Vaccination Consensus StatementEAN Moderator: Melinda Magyari (Copenhagen, Denmark)
Special Moderator: Brett Drummond (Melbourne, Australia)
Guest: Susana Otero (Barcelona, Spain)
In this episode eanCast: Weekly Neurology is joined by The ECTRIMS Podcast. Hosts Melinda Magyari and Br
EAN Moderator: Melinda Magyari (Copenhagen, Denmark)Special Moderator: Brett Drummond (Melbourne, Australia)Guest: Susana Otero (Barcelona, Spain)In this episode eanCast: Weekly Neurology is joined by The ECTRIMS Podcast. Hosts Melinda Magyari and Brett Drummond talk about the ECTRIMS-EAN Vaccination Consensus Statement with lead author Susana Otero. Find the full article here.
2024-09-0232 min
NeuroFrontiersThe Impact of ECTRIMS Over 40 Years
Guest: Mar Tintore, MD
A special guest will be joining the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024 annual meeting on opening day. To learn more about the impact ECTRIMS has had on multiple sclerosis patients over the last 40 years, tune in with Dr. Mar Tintoré, President of ECTRIMS and Clinical Coordinator of the Multiple Sclerosis Centre of Catalonia Cemcat at the Hospital Vall d’Hebron in Barcelona, Spain.2024-08-0200 minNeuroFrontiersKey Highlights from ECTRIMS 2024
Guest: Mar Tintore, MD
The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024 annual meeting is celebrating its 40th anniversary in Copenhagen, Denmark. 9,000 delegates from all over the world are expected to attend this multiday event, which will include keynote lectures, poster sessions, and selected scientific and educational sessions, as well as plenty of philanthropic and networking opportunities and more. Tune in for a brief overview with Dr. Mar Tintoré, President of ECTRIMS and Clinical Coordinator of the Multiple Sclerosis Centre of Catalonia Cemcat at the Hospital Vall d’Hebron in Barcelona, Spain.2024-08-0200 minNeuroFrontiersThe Impact of ECTRIMS Over 40 Years
Guest: Mar Tintore, MD
A special guest will be joining the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024 annual meeting on opening day. To learn more about the impact ECTRIMS has had on multiple sclerosis patients over the last 40 years, tune in with Dr. Mar Tintoré, President of ECTRIMS and Clinical Coordinator of the Multiple Sclerosis Centre of Catalonia Cemcat at the Hospital Vall d’Hebron in Barcelona, Spain.2024-08-0200 minNeuroFrontiersKey Highlights from ECTRIMS 2024
Guest: Mar Tintore, MD
The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2024 annual meeting is celebrating its 40th anniversary in Copenhagen, Denmark. 9,000 delegates from all over the world are expected to attend this multiday event, which will include keynote lectures, poster sessions, and selected scientific and educational sessions, as well as plenty of philanthropic and networking opportunities and more. Tune in for a brief overview with Dr. Mar Tintoré, President of ECTRIMS and Clinical Coordinator of the Multiple Sclerosis Centre of Catalonia Cemcat at the Hospital Vall d’Hebron in Barcelona, Spain.2024-08-0200 min
Esclerosis en la OndaNeuróloga Patricia Mulero en ECTRIMSEn el programa de hoy nuestra neuróloga de referencia nos cuenta su experiencia como asistente en la 9ª edición del ECTRIMS del pasado mes de octubre en Milán.2024-01-0834 min
Esclerosis en la OndaECTRIMS con la neuróloga Patricia MuleroEn el programa de hoy nuestra neuróloga de referencia nos cuenta su experiencia como asistente en la 9ª edición del ECTRIMS del pasado mes de octubre en Milán.2024-01-0834 min
Klinisch Relevant PodcastECTRIMS 2023: Take Home Messages - mit PD Dr. med. Marc PawlitzkiImpfung, BTK-Inhibitoren und mehr..
Pawlitzki, M. (2023, 7. November), ECTRIMS 2023: Take Home messages [Audio-Podcast] in Klinisch Relevant Podcast
Link:
https://open.spotify.com/episode/41OaheyyqGNl80K78SBc45?si=92yCiyOjQ5CgGe_lgblVuw
Der ECTRIMS-Kongress hat in der MS-Fachwelt einen hohen Stellenwert und gehört zu den wichtigsten Veranstaltungen des Jahres.
Marc Pawlitzki, Oberarzt und Leiter der MS-Ambulanz an der Uniklinik Düsseldorf, war vor Ort und teilt mit Euch in diesem Podcast seine Take Home messages.
Zwar hat es die erhofften Studienergebnisse zu den BTK-Inhibitoren noch nicht gegeben, dennoch gab es aus Marcs Sicht wichtige Forschungsergebnisse und Themen: MS...2023-11-0719 min
MS-Perspektive - der Multiple Sklerose PodcastECTRIMS 2023. Tag 3. Pädiatrische MS. Frauengesundheit. Prodromale MS. Stammzelltherapie bei MS.Überblick zu den Vorträgen über pädiatrische MS, Frauengesundheit bei MS, der prodromalen MS und Erfahrungen zur Stammzelltherapie bei MS. Du findest den vollständigen Blogbeitrag zum Nachlesen unter folgendem Link auf meiner Webseite: https://ms-perspektive.de/223-ectrims-2023-tag-3 Der dritte Tag auf der MS Mailand 2023 bot wieder viele interessante Themen. Dieses Mal habe ich die folgenden ausgewählt: Pädiatrische2023-11-0242 min
MS-Perspektive - der Multiple Sklerose PodcastECTRIMS 2023. Tag 2. Menopause. Wirksamkeit der Behandlung. Immunrekonstitutionstherapie. Gesunder Lebensstil.Wie wirkt die Menopause auf die MS? Wirksamkeit verschiedener Behandlungsalgorithmen inkl. Immunrekonstitutionstherapie. Gesunde Lebensweise. Du findest den vollständigen Artikel zum Nachlesen auf meinem Blog: https://ms-perspektive.de/222-ectrims-2023-tag-2 Der zweite Tag auf der MS Mailand 2023 war wieder vollgepackt mit vielen wertvollen Informationen. Und so viele spannende Vorträge fanden gleichzeitig statt. Ich werde2023-10-3037 min
RealTalk MSECTRIMS EXTRA: Dr. Robert MotlWith more than 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Robert Motl. Dr. Motl is a professor in the department of Kinesiology and Nutrition, and a professor in the department of Rehabilitation Sciences at the University of Illinois Chicago. Dr. Motl is r...2023-10-2910 min
RealTalk MSECTRIMS EXTRA with Dr. Daniel OntanedaWith more than 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Daniel Ontaneda. Dr. Ontaneda is a neurologist at the Cleveland Clinic Neurological Institute's Mellen Center for Multiple Sclerosis and, while attending the ECTRIMS-ACTRIMS meeting, Dr. Ontaneda co-chaired a scientific session on artificial i...2023-10-2809 min
MS-Perspektive - der Multiple Sklerose Podcast#221: ECTRIMS 2023. 10 Top-Themen und meine Highlights von Tag 1Überblick über die Themen des ECTRIMS 2023. Detaillierter Einblick in die Vision der Heilung von MS, MS und EBV und MS bei älteren Menschen. Du kannst den kompletten Beitrag auf meinem Blog nachlesen: https://ms-perspektive.de/221-ectrims-2023-tag-1 2023-10-2726 min
RealTalk MSECTRIMS EXTRA: Dr. Annette Langer-GouldWith more than 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Annette Langer-Gould. Dr. Langer-Gould is an MS Specialist at Kaiser-Permanente, and while at the ECTRIMS-ACTRIMS meeting, she co-chaired a session on MS and comorbidities. We have a lot to talk ab...2023-10-2706 min
RealTalk MSECTRIMS EXTRA with Dr. Anthony FeinsteinWith more than 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Anthony Feinstein. Dr. Feinstein is a Professor of Psychiatry at the University of Toronto, and his expertise is in the neuropsychiatry of multiple sclerosis. Dr. Feinstein has studied behavioral disorders in people l...2023-10-2608 min
BeewellwithMS podcast by Dr Agne StraukieneUnlocking Healthy Lifestyle with MS: ECTRIMS 2023 Highlights and Expert InsightsWelcome to 'BeeWellwithMS,' where I, Dr. Agne Straukiene, a neurologist dedicated to enhancing the lives of those with Multiple Sclerosis, dive into the exciting world of MS research. In this episode, I'm thrilled to summarize the groundbreaking presentations from ECTRIMS 2023 by some of the brightest minds in the field.Join me as I break down the insights and discoveries from renowned researchers like Barbara Seebacher, who's exploring the power of music in improving mobility, and Ilana Katz Sand, shedding light on the crucial role of diet and vitamin D.We'll also delve into the world of exercise with insights...2023-10-2539 min
MS-Perspektive - The Multiple Sclerosis PodcastECTRIMS 2023. Day 3. Paediatric MS. Female Health. Prodromic MS. HSCT in MS.Pediatric MS. Female Health. Prodromic MS - can the risk of conversion be reduced? HSCT in MS - new perspectives. You can find the full text to read on my blog: https://ms-perspektive.com/032-ectrims-2023-day-3 The third day at MS Milan 2023 offered again lots of interesting topics. This time I selected the following ones: Paediatric MS Female health Prodromic MS HSCT in MS 2023-10-2531 min
RealTalk MSEpisode 321: More from the 2023 Joint ECTRIMS-ACTRIMS Meeting with Dr. Helen TremlettThis week, we're sharing more from the 2023 joint ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) and ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis) annual meeting. What if we could identify MS before anyone experienced any of the typical clinical symptoms? Would treating that person with a high-efficacy disease-modifying therapy prevent the clinical symptoms of MS from even developing? Those are the questions that make the study of the MS prodrome so fascinating and important. At the joint ECTRIMS-ACTRIMS meeting, I met up with one of the foremost experts on the prodromal...2023-10-2322 min
MS-Perspektive - The Multiple Sclerosis PodcastECTRIMS 2023. Day 2. Menopause. Treatment Efficacy. Immune Reconstitution Therapy. Healthy Lifestyle.Effect of menopause on MS progression? Efficacy of different treatment algorithms incl. immune reconstitution therapy. Healthy lifestyle. You can find the written version to read on my blog: https://ms-perspektive.com/031-ectrims-2023-day-2 The second day at MS Milan 2023 was again packed with lots of valuable information. And so many exciting presentations happened at the sa2023-10-2328 min
NeurologyLive® Mind Moments®2023 ECTRIMS-ACTRIMS Meeting HighlightsWelcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with a variety of specialists in neurology who presented research and gave talks at MSMilan, the joint ECTRIMS-ACTRIMS meeting, held October 11-13, in Milan, Italy. Those included in this week's episode, in order of appearance, are:
Mitzi Joi Williams, MD, founder and chief executive officer of the Joi Life Wellness Group Multiple Sclerosis Center.
Rhonda Voskuhl, the director of the Multiple Sclerosis Program at UCLA.
Tom Fuchs, MD, Ph...2023-10-2015 min
RealTalk MSECTRIMS EXTRA with Dr. Jiwon OhWith about 9,000 MS researchers and clinicians in attendance, the 2023 combined ECTRIMS-ACTRIMS meeting in Milan was the largest MS research conference in the world. During the meeting, I had an opportunity to talk with some of the best and brightest minds in MS research and clinical practice. This is your invitation to listen in on my ECTRIMS EXTRA conversation with Dr. Jiwon Oh. Dr. Oh is a neurologist, scientist, and the Medical Director of the Barlo Multiple Sclerosis Program at St. Michael's Hospital in Toronto, Canada. We have a lot to talk ab...2023-10-2010 min
MS-Perspektive - The Multiple Sclerosis PodcastECTRIMS 2023. 10 Hot Topics and my highlights of day 1Overview on the hot topics of ECTRIMS 2023 and detailed look into the vision of curing MS, MS and EBV and MS in the elderly. you can read the full text with some more details on the statistics of the trials on my blog: https://ms-perspektive.com/030-ectrims-2023-day-1 MS Milan 2023 was the 9th joint meeting of the European ECTRIMS and American ACTRIMS congress. Over 8,6002023-10-1920 min
RealTalk MSFrom ECTRIMS-ACTRIMS 2023 with Bonnie Higgins and Dr. Tim CoetzeeLast week, more than 9,000 MS research scientists and clinicians from more than 110 countries traveled to Milan to attend the largest MS research conference in the world, the 2023 joint ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) and ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis) annual meeting. In keeping with a RealTalk MS tradition, just as the meeting was ending and the thousands of attendees were heading for the exits, I connected with the National MS Society's Chief Advocacy, Services, and Science Officer, Dr. Tim Coetzee, to discuss some of the research that...2023-10-1717 min
Nervennahrung Neurologie PodcastECTRIMS Kongress 2023 Tag 2, Hellwig & Albrecht | Nervennahrung Podcast ECTRIMS 2023
Dieses Jahr berichten Frau Prof. Hellwig und Herr Prof. Albrecht vom ECTRIMS in Mailand über klinisch-relevante Beiträge aus der Multiplen Sklerose und anderen neuroimmunologischen Erkrankungen.
Die nächste reguläre Episode des Roche Nervennahrung-Podcast erscheint Ende Oktober. Unser Archiv sowie weitere Episoden des Podcasts finden Sie zudem unter:
https://www.portal.roche.de/products/neurologie/nervennahrung-podcast-neurologie.html
Bei unserem Nervennahrung-Podcast handelt es sich um Fortbildungsinhalte für Ärzte und
medizinisches Personal und keinesfalls um individuelle Therapievorschläge. Sie ersetzen
also keineswegs einen Arztkontakt, wenn es um die Behandlung von Erkrankungen geht.
Dabei spiegeln die Beiträge den Kenntnisstand unserer...2023-10-1420 min
MS TalkMS Talk: ECTRIMS 2023
Op 11, 12 en 13 oktober vinden in Milaan de jaarlijkse ECTRIMS plaats. Neuroloog Gerald Hengstman is daarbij aanwezig en maakt speciaal voor deze aflevering contact met Nederland om vanuit Milaan, vers van de pers, te vertellen over de laatste ontwikkelingen op het gebied van MS. Hij praat ons bij over waar er tijdens de ECTRIMS vooral over wordt gesproken en waarover juist niet of veel minder.
Wij bedanken @Gashunters voor de muziek.
2023-10-1318 min
Nervennahrung Neurologie PodcastECTRIMS Kongress 2023 Tag 1, Hellwig & Albrecht | Nervennahrung Podcast ECTRIMS 2023
Dieses Jahr berichten Frau Prof. Hellwig und Herr Prof. Albrecht vom ECTRIMS in Mailand über klinisch-relevante Beiträge aus der Multiplen Sklerose und anderen neuroimmunologischen Erkrankungen.
Die nächste Episode des Roche Nervennahrung-Podcast erscheint morgen mit Tag 2 des ECTRIMS. Unser Archiv sowie weitere Episoden des Podcasts finden Sie zudem unter:
https://www.portal.roche.de/products/neurologie/nervennahrung-podcast-neurologie.html
Bei unserem Nervennahrung-Podcast handelt es sich um Fortbildungsinhalte für Ärzte und
medizinisches Personal und keinesfalls um individuelle Therapievorschläge. Sie ersetzen
also keineswegs einen Arztkontakt, wenn es um die Behandlung von Erkrankungen geht.
Dabei spiegeln die Beiträge den Kenntnisstand unserer...2023-10-1319 min
The ECTRIMS PodcastECTRIMS 2022 For People with MS: Part 2Dr. Brigit de Jong from Amsterdam UMC and Professor Alan Thompson from Queens Square Institute of Neurology in London discuss promising, new short-term research data for people with MS unveiled in October during ECTRIMS 2022.2022-12-2140 min
The ECTRIMS PodcastECTRIMS 2022 For People with MS: Part 1Dr. Daniel Ontaneda from the Cleveland Clinic speaks about promising, new mid-term research data for people with MS unveiled during the October 2022 ECTRIMS Congress. 2022-12-1738 min
RealTalk MSECTRIMS Research Update Part 2 with Dr. Bruce BeboSome of you might remember that at the end of October, I was in Amsterdam, attending the 2022 ECTRIMS Congress. ECTRIMS is an acronym for the European Committee for Treatment and Research in Multiple Sclerosis, and their annual scientific congress is the largest MS research conference in the world. As the conference ended, I sat on some steps outside the conference center alongside the National MS Society's Executive Vice-President of Research, Dr. Bruce Bebo. And Dr. Bebo shared his initial impressions of some of the research that had been presented over the 3-day conference. If you missed that episode of t...2022-12-1236 min
The ECTRIMS PodcastThe role of the MS nurse & the need for more globally: an ECTRIMS 2022 recapJoelle Massouh from Harley Street Medical Centre and Piet Eelen from Nationaal MS Centrum talk about the key takeaways of the Nurse Sessions at ECTRIMS 2022, including how the role of the MS nurses has changed over the years, as well as why we need more MS nurses globally and what is being done about it.2022-11-1627 min
MS News & PerspectivesPoor Myelin Repair Offers Clues in Disease Progression & ECTRIMS and Other MS NewsMultiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads about a study that shows how new myelin production may be less efficient in late-onset multiple sclerosis patients, which could underlie more severe disease progression.
He also reads “MS News That Caught My Eye Last Week: ECTRIMS, Ocrevus, Kesimpta, Epstein-Barr, DMTs” by Ed Tobias, from his column “The MS Wire”.
===================================
Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
=====================================
To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
2022-11-0912 minNeurologyLive® Mind Moments®ECTRIMS 2022 and the Latest in MS AdvancesWelcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.
In this episode, we spoke with a number of experts in the clinical care of MS who were in attendance at the 2022 ECTRIMS Congress, including Darin T. Okuda, MD, FAAN, FANA, director of Neuroinnovation and Multiple Sclerosis & Neuroimmunology Imaging Program at UT Southwestern Medical Center; Federica Picariello, PhD, a health psychologist and postgraduate research associate at King's College London; Brenda Banwell, MD, chief of the Division of Neurology and codirector of the Neuroscience Center at th...2022-11-0434 min
RealTalk MSFrom the 2022 ECTRIMS Congress with Dr. Bruce BeboLast week, over 7,000 MS researchers and clinicians from more than 100 countries traveled to Amsterdam to attend the 2022 ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) Congress, the largest MS research conference in the world. As has become an annual ECTRIMS tradition on RealTalk MS, the National MS Society's Executive Vice-President of Research, Dr. Bruce Bebo, and I took up our vantage point on the steps right outside of the convention center to discuss the research that captured Dr. Bebo's attention. We have a lot to talk about! Are you ready for RealTalk MS??!2022-10-3122 min
MS-SelfieECTRIMS 2022 - highlightsI have just arrived back from ECTRIMS 2022 in Amsterdam and have reflected on a week of meetings. I had little time to view abstracts and/or attend live sessions. I am hoping to catch up with missed content using the on-demand service. Despite this, I managed to get an overview of what is important from discussions with friends and colleagues. 1. EBVEBV remains, in my opinion, on top of the pops. The good news is that almost all of the pharmaceutical companies I spoke to are now including EBV in their long-term thinking. Some companies ar...2022-10-3121 min
The ECTRIMS PodcastECTRIMS 2022 Wrap-upListen to ECTRIMS President Mar Tintoré wrap up the key takeaways from ECTRIMS 2022, as well as highlight what you can expect from ECTRIMS’ new 365 programme.2022-10-2924 min
MS-Perspektive - der Multiple Sklerose PodcastSpezial ECTRIMS 2022 - Tag 3 - Zur Bedeutung früher leichter Schübe, aHSCT und Natalizumab im Vergleich bei Behandlung von progredienter MS und der PROMS Initiative In der 3. Folge vom ECTRIMS 2022 berichte ich von drei Themenblöcken: Early non-disabling relapses are associated with a higher risk of disability accumulation in people with relapsing-remitting multiple sclerosis / Frühe, nicht behindernde Schübe sind bei Menschen mit schubförmig remittierender Multipler Sklerose mit einem höheren Risiko für die Anhäufung von Behinderungen verbunden von Cyrus Daruwalla von der University of Cambridge, Großbritannien Effectiveness of autologous haematopoietic stem cell transplantation in comparison with natalizumab in progressive MS / Wirksamkeit der autologen hämatopoetischen Stammzelltransplantation im Vergleich zu Natalizumab bei progredienter MS von Tomas Kalincik von The Royal...2022-10-2936 min
The ECTRIMS PodcastDay Two Highlights of ECTRIMS 2022Listen to Timothy Coetzee – Chief Advocacy, Services & Science Officer at the National MS Society – discuss the most relevant insights from day two of ECTRIMS 2022.2022-10-2818 min
Nervennahrung Neurologie PodcastECTRIMS Kongress 2022 Tag 2, Mäurer & Meuth | Nervennahrung Podcast ECTRIMS 2022
Die Nervennahrung Neuro News des zweiten Tages des ECTRIMS Kongress 2022 in Amsterdam.
Die Professoren Sven Meuth und Mathias Mäurer berichten täglich vom aktuellen ECTRIMS Kongress in Amsterdam über klinisch-relevante Beiträge aus allen Bereichen der Neurologie.
Die nächste Episode des Roche Nervennahrung-Podcast erscheint nächste Woche, gefolgt von den Neuro News von der Neurowoche Berlin. Unser Archiv sowie weitere Episoden des Podcasts finden Sie zudem unter:
https://www.portal.roche.de/products/neurologie/nervennahrung-podcast-neurologie.html
Bei unserem Nervennahrung-Podcast handelt es sich um Fortbildungsinhalte für Ärzte und
medizinisches Personal und keinesfalls um individuelle Therapievorschläge. Sie ersetzen
also kein...2022-10-2816 min
MS-Perspektive - der Multiple Sklerose PodcastSpezial ECTRIMS 2022 - Tag 2 - Frühe Prognosefaktoren für Behandlungserfolg, Eskalieren und Deeskalieren von Therapien sowie Progrediente MS In der 2. Folge vom ECTRIMS 2022 berichte ich von drei Themenblöcken: Early predictors of treatment outcome / Frühe Prädiktoren für den Behandlungserfolg von Xavier Montalban vom MS Centre of Catalonia Hot Topic 5: Escalating and de-escalating DMTs / Eskalieren und Deeskalieren von verlaufsmodifizierenden Medikamenten Treating active MS following induction therapies / Behandlung der aktiven MS nach Induktionstherapien von Gilles Edan der CHU Renne, Frankreich Long-term stable MS on high-efficacy therapies / Langfristig stabile MS unter hochwirksamen Therapien von Emmanuelle Wubant von der University of California, San Francisco, USA Long-term stable MS on platform therapies / Langfristig stabile MS unter Basi...2022-10-2755 min
The ECTRIMS PodcastDay One Highlights of ECTRIMS 2022Listen to Brenda Banwell – the ECTRIMS 2022 Keynote Lecturer – deep dive into the key takeaways of the first day of ECTRIMS 2022.2022-10-2726 min
Nervennahrung Neurologie PodcastECTRIMS Kongress 2022 Tag 1, Mäurer & Meuth | Nervennahrung Podcast ECTRIMS 2022
Die Nervennahrung Neuro News des ersten Tages des ECTRIMS Kongress 2022 in Amsterdam.
Die Professoren Sven Meuth und Mathias Mäurer berichten täglich vom aktuellen ECTRIMS Kongress in Amsterdam über klinisch-relevante Beiträge aus allen Bereichen der Neurologie.
Die nächste Episode des Roche Nervennahrung-Podcast Spezials zum ECTRIMS erscheint morgen, am 28.10.2022. Unser Archiv sowie weitere Episoden des Podcasts finden Sie zudem unter:
https://www.portal.roche.de/products/neurologie/nervennahrung-podcast-neurologie.html
Bei unserem Nervennahrung-Podcast handelt es sich um Fortbildungsinhalte für Ärzte und
medizinisches Personal und keinesfalls um individuelle Therapievorschläge. Sie ersetzen
also keineswegs einen Arztkontakt, wenn es um die Beha...2022-10-2714 min
MS-Perspektive - der Multiple Sklerose PodcastSpezial ECTRIMS 2022 - Tag 1 - Die Pyramide auf den Kopf stellen und Kindliche MSECTRIMS steht für European Commitee for Treatment and Research in Multiple Sclerosis. Dieses Komitee veranstaltet einen jährlichen Kongress, an dem man mittlerweile auch online teilnehmen kann. Dank meinem Blog, bin ich akkreditierte Pressevertreterin und will Dir punktuelle Einblicke in die dreitägige Veranstaltung vom 26. bis 28.10.2022 geben. Hier geht es zum Blogbeitrag: https://ms-perspektive.de/spezial-ectrims-2022 In dieser Folge habe ich zwei Vorträge gewählt: Flipping the pyramid / Die Pyramide auf den Kopf stellen von Gavin Giovannoni vom Barts and The London School of Medicine and Dentistry, Großbritan...2022-10-2647 min
MS-SelfieECTRIMS 2022 - initial thoughtsI arrived last night in Amsterdam for this year’s ECTRIMS meeting. Our first real face-to-face meeting of MS researchers and HCPs in three years. I am giving several talks and poster presentations. However, I will spend most of this ECTRIMS having meetings. Yes, this happens at conferences; it is all about networking and is why international travel to conferences will continue despite the large environmental impact.EBVIt is clear that since arriving and speaking to colleagues, the buzz around EBV has not decreased. Saying this, the programme does not include much new work on...2022-10-2508 minThe ECTRIMS PodcastNEW! The ECTRIMS PodcastWelcome to the ECTRIMS podcast, the new sounding board for the MS research community. Tune in on the 27th, 28th and 29th of October for the official debut of The ECTRIMS Podcast. Enjoy back-to-back episodes of each day of congress, and stay up to date on all the key happenings unfolding at the world’s largest international congress for MS research.2022-10-1701 min
RealTalk MSRe-Visiting Our ECTRIMS 2021 Research Review with Dr. Bruce BeboToday, we're re-visiting my favorite conversation of the entire year and it seems that you and I agree! You've made it this year's most downloaded and listened-to episode. In this episode, Dr. Bruce Bebo, the Executive Vice-President of Research at the National MS Society, briefs us about some of the most interesting and important research shared at ECTRIMS 2021, the largest MS research conference in the world. We have a lot to talk about! Are you ready for RealTalk MS??! Wishing you a happy and healthy new year! :22 ECTRIMS 2021 research r...2021-12-2835 min
RealTalk MSECTRIMS 2021 Research Wrap-Up with Dr. Bruce BeboJust a couple of weeks ago, 9,000 MS research scientists and clinicians from 100 countries gathered virtually for the annual meeting of the European Committee for Treatment and Research in Multiple Sclerosis, otherwise known as ECTRIMS. The largest MS research conference in the world lived up to its name, featuring 200 speakers and 1,700 research abstracts. In what has become an annual RealTalk MS tradition, Dr. Bruce Bebo, the Executive Vice President of Research at the National MS Society, joins us to share his thoughts about the research presented at ECTRIMS that will lead to treatments designed to stop...2021-11-0134 min
MS PodcastsResearch update: ECTRIMS 2021 highlights with Brett Drummond from MStranslateJoin Nicola Graham as she talks with Brett Drummond, the co-founder of MStranslate. Brett provides a summary of the highlights of ECTRIMs 2021, the largest global congress for MS researchers. Brett shares with us the most exciting and surprising MS research presented. Some topics covered include the latest on re-myelination therapies, COVID and vaccines for people living with MS, Gut Microbiome, Symptom Management and Stem Cell therapies.With thanks to Brett.Reach out for support:MS Plus Connect 1800 042 138 or email connect@msplus.org.auGet in touch to share your comments and suggestions ab...2021-10-2236 min
MS TalkMS Talk Extra 9: Dag 3 van de Ectrims18 oktober 2021
Op 13, 14 en 15 oktober 2021 vindt het grootste wereldwijde congres over MS plaats; de Ectrims. Vanuit Schoorl waar dr. Gerald Hengstman live dit congres digitaal volgt brengt hij direct verslag uit van de nieuwste onderzoeken en inzichten.
In deze laatste aflevering over de Ectrims van 2021 gaat het onder meer over het stoppen met medicatie.
Wij bedanken Hans Geurts van Twoomusic wederom voor de muziek!2021-10-1814 min
Health Professional Radio - PodcastECTRIMS Virtual Congress 2021 - PONVORY™ In Patients With Relapsing Forms of Multiple SclerosisECTRIMS Virtual Congress 2021 - PONVORY™ In Patients With Relapsing Forms of Multiple Sclerosis by Vertical Internet Media2021-10-1812 min
MS TalkMS Talk Extra 8: Dag 2 van de Ectrims15 oktober 2021
Op 13, 14 en 15 oktober 2021 vindt het grootste wereldwijde congres op basis van MS plaats; de Ectrims. Vanuit Schoorl waar dr. Gerald Hengstman live dit congres digitaal volgt brengt hij direct verslag uit van de nieuwste onderzoeken en inzichten.
In deze aflevering onder andere: er wordt volop onderzoek gedaan naar een nieuw medicijn voor mensen met PPMS en een gezonde leefstijl heeft een positief effect bij MS.
Wij bedanken Hans Geurts van Twoomusic wederom voor de muziek!2021-10-1511 min
MS TalkMS Talk Extra: dag 1 van de Ectrims 2021Op 13, 14 en 15 oktober 2021 vindt het grootste wereldwijde congres op basis van MS plaats; de Ectrims. Vanuit Schoorl waar dr. Gerald Hengstman live dit congres digitaal volgt brengt hij direct verslag uit van de nieuwste onderzoeken en inzichten.
In deze aflevering onder andere: is het zinvol om zo snel mogelijk met hoog effectieve medicijnen MS te gaan behandelen? Wanneer en hoe is een 3e Coronavaccinatie aan te bevelen? Heeft het gebruik van Melatonine een gunstig effect op slaapproblemen bij MS? en een nieuwe manier van behandeling bij het Restless Legs Syndrome.
Wij bedanken Hans Geurts wederom vo...2021-10-1423 min
Health Professional Radio - PodcastACTRIMS-ECTRIMS Multiple Sclerosis Therapeutics and ResearchReturning guest, Dr. Jeffrey Cohen, Nephrologist with the Cleveland Clinic, a renowned leader in Multiple Sclerosis research and President of ACTRIMS, the world's largest conference focused on MS research, discusses highlights from the 8th Joint ACTRIMS-ECTRIMS (the European counterpart) Conference (MSVirtual2020). He talks about advancements in therapeutics, outcomes of clinical trials, and the impact of COVID on clinical research and patient care.2020-08-2800 min
Health Professional Radio - PodcastACTRIMS-ECTRIMS Multiple Sclerosis Treatments and Developments in DiagnosticsDr. Jeffrey Cohen, a Neurologist with the Cleveland Clinic, a renowned leader in Multiple Sclerosis research and the President of ACTRIMS, the world’s largest conference focused on MS research, discusses highlights from the 8th Joint ACTRIMS-ECTRIMS (the European counterpart) Conference (MSVirtual2020). He talks about cutting edge research into the cause of MS, personalized medicine, new developments in diagnosing MS, and the role of biomarkers in the diagnostic process.2020-08-2800 min
RealTalk MSECTRIMS 2019 Research Recap With Dr. Bruce BeboIn this episode of RealTalk MS, we're re-visiting my conversation from ECTRIMS 2019 with Dr. Bruce Bebo, the Executive Vice-President of Research at the National MS Society. This is one of my favorite conversations of the entire year, and you've made it this year's most downloaded and listened to RealTalk MS episode. We're also talking about a new report issued by RAND Europe, entitled Exploring the Societal Burden of Multiple Sclerosis: A Study Into the Non-Clinical Impact of the Disease, Including Changes with Progression. And if you have the RealTalk MS app installed on your iOS or Android s...2019-12-2729 min
RealTalk MSBonus Episode: ECTRIMS 2019 Day ThreeWelcome to a special episode of RealTalk MS coming to you from Day Three of ECTRIMS 2019 in Stockholm, Sweden. This final day at ECTRIMS has become my favorite day of the conference because it's the day that I get to sit down with Dr. Bruce Bebo, the Executive Vice President of Research at the National MS Society, and get his perspective on the highlights of the entire conference. We're talking about new Phase 3 clinical trial outcomes, research that shows that lifestyle choices can impact the course and severity of MS, the importance of beginning disease-modifying therapy within 5 years of being...2019-09-1326 min
RealTalk MSBonus Episode: ECTRIMS 2019 Day TwoWelcome to a special episode of RealTalk MS coming to you from Day Two of ECTRIMS 2019 in Stockholm, Sweden. ECTRIMS is an acronym that stands for the European Conference for Treatment & Research in Multiple Sclerosis, and this annual scientific congress is the largest MS research conference in the world. There are over 9,000 attendees here from more than 100 different countries to share new information, hear research updates, and get face to face with the leading MS researchers in the world. We're talking about stem cell therapy, the long-term outcomes of MS, new data about Ocrevus, the importance of managing comorbidities, and a...2019-09-1210 min
RealTalk MSBonus Episode: ECTRIMS 2019 Day 1Welcome to a special episode of RealTalk MS coming to you from ECTRIMS 2019 in Stockholm, Sweden. ECTRIMS is an acronym that stands for the European Conference for Treatment & Research in Multiple Sclerosis, and this annual scientific congress is the largest MS research conference in the world. There are over 9,000 attendees here from more than 100 different countries to share new information, hear research updates, and get face to face with the leading MS researchers in the world. We're talking about some of the announcements that we expect to hear from some of the pharmaceutical companies in attendance. And we'll also tell y...2019-09-1109 min
RealTalk MSECTRIMS 2018 Wrap-UpI'm back from Berlin, Germany, where I attended the 34th annual ECTRIMS Congress, and the single biggest challenge that I faced during the 3-day conference was trying to decide which sessions I wanted to attend. With 80 live presentations, more than 1,000 poster presentations, and any number of meetings and even casual conversations that seem to pop up everywhere, it's challenging trying to take it all in. Although ECTRIMS has ended, there's still a bit more to report from the conference, so please consider this podcast episode as the ECTRIMS wrap-up. We're talking about the effectiveness of a ...2018-10-1623 min
RealTalk MSLive from Day 3 of ECTRIMS 2018It's the 3rd and final day at ECTRIMS in Berlin! Today, we're taking you to a special documentary screening that we've been keeping under wraps! (You can watch the trailer as part of the "Bonus" content in the RealTalk MS app!) We're talking about the amazing changes in almost every aspect of how we look at MS that have all taken place within just 25 years. We'll walk you through a couple of the scientific sessions that really stood out earlier today. And we'll tell you how you can find scientific victory in the midst of what some...2018-10-1312 min
RealTalk MSEpisode 58: Live from Day 2 of ECTRIMS 2018It's Day 2 at ECTRIMS in Berlin! Today, we're talking about the Shift.ms booth in the Exhibition Hall, where you can take part in a virtual reality demonstration of what it might be like to accomplish even the simplest tasks if you're living with MS. And if you've downloaded the RealTalk MS app from the Apple App Store for iOS or the Google Play Store for Android, I hope you enjoy the bonus video of the virtual reality demonstration that I shot on the Exhibition Hall floor. I wanted to get an expert's opinion about which ECTRIMS presentations w...2018-10-1217 min
RealTalk MSLive from Day 1 at ECTRIMS 2018Greetings from Day 1 at ECTRIMS in Berlin! Today, we're talking about pharmaceutical company Novartis seeking approval from the U.S. Food & Drug Administration and the European Medicines Agency for siponimod, a once-daily oral medication that significantly reduces disability progression for people living with secondary progressive MS. This is important news, as 80% of the people living with relapsing remitting MS are eventually diagnosed with secondary progressive MS. And currently, there is no approved disease modifying therapy for secondary progressive MS. The FDA has fast-tracked the approval process, and siponimod could gain the necessary regulatory approval in the U.S. b...2018-10-1114 min
RealTalk MSOn the Road to ECTRIMSThis week, the European Committee for Treatment and Research in Multiple Sclerosis is hosting the ECTRIMS 2018 Congress in Berlin, Germany. It's the largest MS conference in the world. And you can look forward to special episodes of RealTalk MS direct from ECTRIMS, on Wednesday, Thursday, and Friday, October 10th, 11th, and 12th! You'll get the news, hear the interviews, and you'll be the first to get the research updates and announcements as they're being made at the largest MS conference in the world. And if you have the RealTalk MS app (available free at the Apple App Store and the Go...2018-10-0916 min
RealTalk MSECTRIMS 2017 Round-UpLast week, more than 9,000 MS research scientists, physicians, and pharmaceutical industry experts attended ECTRIMS-ACTRIMS, the largest annual international MS research conference in the world. And we're devoting this week's podcast episode to talking about what they were talking about! Welcome to the RealTalk MS ECTRIMS Round-Up! You'll find out about how the "official" number of people with MS in the United States is now more than double what it was before last week. We'll talk about some of the sobering socio-economic effects of MS on women. We'll look at new data from studies on treating Progressive MS, and we'll d...2017-10-3118 min
Medizin - Open Access LMU - Teil 16/22Review: ‘Gimme five’: future challenges in multiple sclerosis. ECTRIMS Lecture 2009This article is based on the ECTRIMS lecture given at the 25th ECTRIMS meeting which was held in Düsseldorf, Germany, from 9 to 12 September 2009. Five challenges have been identified: (1) safeguarding the principles of medical ethics; (2) optimizing the risk/benefit ratio; (3) bridging the gap between multiple sclerosis and experimental autoimmune encephalitis; (4) promoting neuroprotection and repair; and (5) tailoring multiple sclerosis therapy to the individual patient. Each of these challenges will be discussed and placed in the context of current research into the pathogenesis and treatment of multiple sclerosis.2010-01-0100 min